3
Announcements
Trials
Browse
Landscape
Status
Completed
21
Active not recruiting
8
Unknown
3
Terminated
3
Recruiting
2
Withdrawn
1
Available
1
Sponsor Class
INDUSTRY
1
Study Type
Expanded_access
1
Sponsor
Cancer Type
Sarcoma
6
Gynecologic
4
Genitourinary
3
Gastrointestinal
3
Thoracic
2
Lymphoid
2
Breast
2
Plasma cell
1
Myeloid
1
Dermatologic
1
CNS
1
Conditions
Primary Myelofibrosis
2
Myelodysplastic Syndromes
2
Leukemia, Myeloid, Acute
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Hematologic Neoplasms
2
Thalassemia
1
Sarcoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Multiple Myeloma
1
Metabolic Diseases
1
Mastocytosis, Systemic
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Leukemia, Mast-Cell
1
Immunologic Deficiency Syndromes
1
Endometrial Neoplasms
1
Anemia, Sickle Cell
1
Anemia, Aplastic
1
Adrenoleukodystrophy
1
Interventions
selinexor
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Available
×
Sarcoma
×
Myeloid
×
Clear all
NCT07215832
2026-03-02
KEAP
Karyopharm Therapeutics Inc
Available